Dr. Omar H. Llaguna, MD

Bio

Omar H. Llaguna, M.D., is a Board-certified general surgeon with advanced fellowship training in surgical oncology and endocrine surgery and a member of Baptist Health Medical Group, an organization of more than 180 physicians in multiple specialties closely aligned with Baptist Health South Florida. A South Florida native, he graduated from La Immaculata La Salle High School, and earned a bachelor’s degree at the University of Miami and a master’s degree at Nova Southeastern University. He received his medical degree from Ross School of Medicine, where he graduated with high honors, and completed his surgical internship at Maimonides Medical Center, where he received the Surgical Intern of the Year award. Dr. Llaguna completed his general surgery residency at Beth Israel Medical, where he served as chief resident and received multiple awards including the Surgical Resident Scholarly Achievement Award, Albert Einstein College of Medicine Medical Teaching Award and the Society of Laparoendoscopic Surgeons’ Outstanding Laparoendoscopic Resident Award. Dedicated to cancer care, he went on to complete a clinical fellowship in surgical oncology and endocrine surgery at the University of North Carolina School of Medicine. In 2011 he returned to South Florida and partnered with Drs. Juan-Carlos Verdeja, Jorge R. Rabaza, Anthony M. Gonzalez and Jaime Rodriguez of Baptist Health Medical Surgery Group. More recently, he has accepted the appointment of assistant professor of surgery at Florida International University’s Herbert Wertheim College of Medicine. He is a Diplomate of the American Board of Surgery, Associate Fellow of the American College of Surgeons, Fellow of the Society of Surgical Oncology and member of the Americas Hepato-Pancreato-Biliary Association.

Specialties:

Affiliation:

  • Baptist Health South Florida

Location:

  • Baptist Health Medical Group General Sur...
  • 7800 S.W. 87 Avenue
  • MIami, FL
  • 305-271-9777
  • View Contact Info

Group Memberships:

Activity

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, April 23, 2015 (HealthDay News) -- Actress and activist Angelina Jolie made news last month when she announced she had her ovaries removed -- after undergoing a preventive double mastectomy in 2013 -- because she is a carrier of BRCA, a genetic mutation that greatly increases the risk

    ...Full Article
  • Sharecare News
    Sharecare News posted a story about Oncologic Surgery:

    THURSDAY, April 23, 2015 (HealthDay News) -- Breast cancer surgeries have advanced so that surgeons can often remove the tumor while safely conserving the breast, in what's known as lumpectomy.

    But a new study shows that even though this breast-conserving surgery has a high success rate, ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncologic Surgery:

    MONDAY, April 20, 2015 (HealthDay News) -- Lung cancer patients with less income and education are more likely to die within 30 days of cancer surgery than those with more education and money, a new study finds.

    The type of hospital where the surgery occurs also...Full Article

  • Sharecare News
    Sharecare News posted a story about Pulmonary & Respiratory Medicine:

    SUNDAY, April 19, 2015 (HealthDay News) -- A new drug that boosts the immune system's cancer-fighting potential is showing early promise for some patients with advanced lung cancer.

    The drug, marketed as Keytruda, was recently approved in the United States for t...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    WEDNESDAY, April 8, 2015 (HealthDay News) -- More than 20 percent of Medicare patients with melanoma, the deadliest form of skin cancer, face delays in getting surgical treatment, a new study reveals.

    Researchers evaluated more than 32,000 melanoma patients covered by Medicare, the public...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    WEDNESDAY, April 8, 2015 (HealthDay News) -- Pancreatic cancer remains a "silent killer" because it is typically discovered too late for treatment to be very effective.

    Now, a small new study hints -- but cannot prove -- that using MRIs to screen people at high genetic risk for the disea...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    WEDNESDAY, April 8, 2015 (HealthDay News) -- Pancreatic cancer remains a "silent killer" because it is typically discovered too late for treatment to be very effective.

    Now, a small new study hints -- but cannot prove -- that using MRIs to screen people at high genetic risk for the disea...Full Article

  • Sharecare News
    Sharecare News posted a story about General Surgery:

    FRIDAY, April 3, 2015 (HealthDay News) -- Compared with five years ago, women with breast cancer and just one cancerous lymph node are less likely to have most underarm lymph nodes removed, a new study reports.

    The results of the analysis of data from 2.7 million breast cancer patients h...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    SATURDAY, March 28, 2015 (HealthDay News) -- An experimental vaccine and a drug already on the market each may help slow down advanced ovarian cancer, two new studies suggest.

    In one, of just 31 patients, researchers found that adding the vaccine to standard treatment staved off a recurre...Full Article

  • Sharecare News
    Sharecare News posted a story about Otolaryngology:

    THURSDAY, March 19, 2015 (HealthDay News) -- Smoking and heavy drinking seem to increase the risk that patients with head and neck cancer will need a feeding tube for an extended time after treatment, new research suggests.

    The study included 104 patients with squamous cell cancer of the ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    MONDAY, March 9, 2015 (HealthDay News) -- A family history of prostate cancer may be tied to a woman's risk of breast cancer, a new study suggests.

    Women whose father, brother or son have had prostate cancer may have a 14 percent higher risk of developing breast cancer, said Jennifer Beeb...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    WEDNESDAY, March 4, 2015 (HealthDay News) -- U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small cell lung cancer (NSCLC), the agency said Wednesday in a news release.

    Lung cancer is the leading cause of cancer death in the Unit...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    TUESDAY, Feb. 24, 2015 (HealthDay News) -- U.S. recommendations against the PSA test for prostate cancer might have prompted a small but measurable increase in the number of higher-risk cases diagnosed recently, according to a new study.

    The U.S. Preventive Services Task Force (USPSTF) in...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, Feb. 19, 2015 (HealthDay News) -- New research suggests that a wait-and-watch approach for prostate cancer isn't being used often enough, and that more men are being treated than may be necessary.

    Additionally, the researchers expressed concern about the numbers of men being tr...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, Feb. 19, 2015 (HealthDay News) -- Survival rates are improving for many people with cancers of the breast, prostate, lung, liver and colon or rectum, especially for those diagnosed at younger ages, a new study reports.

    Cancer is still a leading cause of death in the United State...Full Article